$2.69
0.37% today
NYSE, Apr 02, 10:00 pm CET
ISIN
US2560861096
Symbol
DCGO

DocGo Target price 2025 - Analyst rating & recommendation

DocGo Classifications & Recommendation:

Buy
86%
Hold
14%

DocGo Price Target

Target Price $5.05
Price $2.68
Potential
Number of Estimates 7
7 Analysts have issued a price target DocGo 2026 . The average DocGo target price is $5.05. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 6 Analysts recommend DocGo to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DocGo stock has an average upside potential 2026 of . Most analysts recommend the DocGo stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 616.56 413.44
1.24% 32.94%
EBITDA Margin 7.23% 4.97%
43.31% 31.25%
Net Margin 2.98% -0.99%
203.76% 133.28%

7 Analysts have issued a sales forecast DocGo 2025 . The average DocGo sales estimate is

$413m
Unlock
. This is
32.94% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$430m 30.25%
Unlock
, the lowest is
$365m 40.80%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $617m 1.24%
2025
$413m 32.94%
Unlock
2026
$447m 8.22%
Unlock
2027
$505m 12.89%
Unlock

6 Analysts have issued an DocGo EBITDA forecast 2025. The average DocGo EBITDA estimate is

$20.6m
Unlock
. This is
53.87% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$22.0m 50.70%
Unlock
, the lowest is
$17.9m 59.84%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $44.6m 41.54%
2025
$20.6m 53.87%
Unlock
2026
$35.8m 73.92%
Unlock
2027
$44.6m 24.83%
Unlock

EBITDA Margin

2024 7.23% 43.31%
2025
4.97% 31.25%
Unlock
2026
7.99% 60.76%
Unlock
2027
8.84% 10.64%
Unlock

6 DocGo Analysts have issued a net profit forecast 2025. The average DocGo net profit estimate is

$-4.1m
Unlock
. This is
122.24% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$13.3m 27.77%
Unlock
, the lowest is
$-11.2m 161.11%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $18.3m 200.00%
2025
$-4.1m 122.24%
Unlock
2026
$6.4m 256.13%
Unlock
2027
$6.1m 4.08%
Unlock

Net Margin

2024 2.98% 203.76%
2025
-0.99% 133.28%
Unlock
2026
1.42% 243.43%
Unlock
2027
1.21% 14.79%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.18 -0.04
200.00% 122.22%
P/E negative
EV/Sales 0.57

6 Analysts have issued a DocGo forecast for earnings per share. The average DocGo EPS is

$-0.04
Unlock
. This is
122.22% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.13 27.78%
Unlock
, the lowest is
$-0.11 161.11%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.18 200.00%
2025
$-0.04 122.22%
Unlock
2026
$0.06 250.00%
Unlock
2027
$0.06 0.00%
Unlock

P/E ratio

Current 14.52 76.67%
2025
-67.00 561.43%
Unlock
2026
42.88 164.00%
Unlock
2027
44.67 4.17%
Unlock

Based on analysts' sales estimates for 2025, the DocGo stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.38 42.42%
2025
0.57 49.92%
Unlock
2026
0.53 7.60%
Unlock
2027
0.47 11.42%
Unlock

P/S ratio

Current 0.44 34.24%
2025
0.66 49.13%
Unlock
2026
0.61 7.59%
Unlock
2027
0.54 11.43%
Unlock

Current DocGo Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
Locked
Locked Feb 28 2025
Stifel
Locked
Locked
Locked Feb 28 2025
Needham
Locked
Locked
Locked Jan 16 2025
Cantor Fitzgerald
Locked
Locked
Locked Sep 20 2024
Cantor Fitzgerald
Locked
Locked
Locked Aug 20 2024
Analyst Rating Date
Locked
Needham:
Locked
Locked
Feb 28 2025
Locked
Stifel:
Locked
Locked
Feb 28 2025
Locked
Needham:
Locked
Locked
Jan 16 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Sep 20 2024
Locked
Cantor Fitzgerald:
Locked
Locked
Aug 20 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today